Global Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Data Survey Report 2025

1 Global Market Overview

1.1 Scope of Statistics

1.1.1 Scope of Products

1.1.2 Scope of Manufacturers

1.1.3 Scope of Application

1.1.5 Scope of Regions/Countries

1.2 Global Market Size

2 Regional Market

2.1 Regional Production

2.2 Regional Demand

2.3 Regional Trade

3 Key Manufacturers

3.1 AstraZeneca Plc 

3.1.2 Company Information

3.1.2 Product Specifications

3.1.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)

3.2 Bristol-Myers Squibb Company 

3.2.1 Company Information

3.2.2 Product Specifications

3.2.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)

3.3 Gilead Sciences Inc 

3.3.1 Company Information

3.3.2 Product Specifications

3.3.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)

3.4 Modus Therapeutics Holding AB 

3.4.1 Company Information

3.4.2 Product Specifications

3.4.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)

3.5 Novartis AG 

3.5.1 Company Information

3.5.2 Product Specifications

3.5.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)

3.6 NuvOx Pharma LLC 

3.6.1 Company Information

3.6.2 Product Specifications

3.6.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)

3.7 NuvOx Pharma LLC 

3.7.1 Company Information

3.7.2 Product Specifications

3.7.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)

3.8 Seattle Genetics Inc 

3.8.1 Company Information

3.8.2 Product Specifications

3.8.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)

4 Major Application

4.1 Clinic 

4.1.1 Overview

4.1.2 Clinic  Market Size and Forecast

4.2 Hospital 

4.2.1 Overview

4.2.2 Hospital  Market Size and Forecast

4.3 Others

4.3.1 Overview

4.3.2 Others Market Size and Forecast

5 Market by Type

5.1 SGD-2083 

5.1.1 Overview

5.1.2 SGD-2083  Market Size and Forecast

5.2 Crizanlizumab 

5.2.1 Overview

5.2.2 Crizanlizumab  Market Size and Forecast

5.3 PF-04447943 

5.3.1 Overview

5.3.2 PF-04447943  Market Size and Forecast

5.4 NVX-508 

5.4.1 Overview

5.4.2 NVX-508  Market Size and Forecast

5.5 Others 

5.5.1 Overview

5.5.2 Others  Market Size and Forecast

5.6 Others 

5.6.1 Overview

5.6.2 Others  Market Size and Forecast

6 Conclusion

Tab Regional Production 2011-2017 (Volume)

Tab Regional Demand and CAGR 2011-2017 (Million USD)

Tab Regional Demand and CAGR 2011-2017 (Volume)

Tab Regional Demand Forecast and CAGR 2018-2025 (Million USD)

Tab Regional Demand Forecast and CAGR 2018-2025 (Volume)

Tab Regional Export 2011-2017 (Million USD)

Tab Regional Export 2011-2017 (Volume)

Tab Regional Import 2011-2017 (Million USD)

Tab Regional Import 2011-2017 (Volume)

Tab Sales Revenue, Volume, Price, Cost and Margin of AstraZeneca Plc 

Tab Sales Revenue, Volume, Price, Cost and Margin of Bristol-Myers Squibb Company 

Tab Sales Revenue, Volume, Price, Cost and Margin of Gilead Sciences Inc 

Tab Sales Revenue, Volume, Price, Cost and Margin of Modus Therapeutics Holding AB 

Tab Sales Revenue, Volume, Price, Cost and Margin of Novartis AG 

Tab Sales Revenue, Volume, Price, Cost and Margin of NuvOx Pharma LLC 

Tab Sales Revenue, Volume, Price, Cost and Margin of NuvOx Pharma LLC 

Tab Sales Revenue, Volume, Price, Cost and Margin of Seattle Genetics Inc